Skip to content
Catalyst

PapersPMID:30701554

Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.

Journal of the science of food and agriculture2019The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, very limited evidencelowersGlycated haemoglobin (HbA1c)
  2. Finding, very limited evidencelowersHOMA-IR
Study, every finding
RCT · 2 months
Dose studied, every finding
3 g/day green cardamom for 10 weeks
Population, every finding
overweight or obese adults with type 2 diabetes mellitus
  • “Compared to the control group, a significant decrease in serum HbA1C (-0.4%), insulin (-2.8 µIU dL-1 ), HOMA-IR (-1.7) and TG (-39.9 mg dL-1 ), and an increase in SIRT1 (2.3 ng mL-1 ) was observed in cardamom group.”

Study record

Design
randomised controlled trial
Species
human
Population
Overweight or obese type 2 diabetic patients; green cardamom 3 g vs rusk powder placebo for 10 weeks (abstract only)
Participants
83
Comparator
placebo
Duration
70 days
Endpoints measured
8